Quantcast

Hawkeye Reporter

Wednesday, September 10, 2025

Iowa: Biologics companies were the second most FDA inspected companies in Iowa in Q1

Webp r4rtnb3h764dx5zlstpe2fag0ycm

Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA | Official Website

Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA | Official Website

In the first quarter of 2025, seven Biologics companies received seven FDA inspections in Iowa, according to the U.S. Food and Drug Administration (FDA).

This was the second highest number of inspections per type of company made by the FDA in Iowa, equalling 41.2% of all inspections in the first quarter of 2025.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.

FDA Inspections in Iowa During Q1
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Blood and Blood Products6
Compliance: Devices1
Food Composition, Standards, Labeling and Econ1
Foodborne Biological Hazards7
Human Cellular, Tissue, and Gene Therapies1
Monitoring of Marketed Animal Drugs, Feed, and Devices1
Postmarket Assurance: Devices1
Technical Assistance: Food and Cosmetics3

MORE NEWS